Mesenteric nitric oxide and superoxide production in experimental necrotizing enterocolitis

Area of Science:

• Neonatal physiology
• Vascular biology
• Gastroenterology

Background:

• Necrotizing enterocolitis (NEC) is a severe intestinal disease in premature infants.
• Vascular dysfunction and altered nitric oxide synthase (NOS) activity are implicated in NEC pathogenesis.
• An imbalance in nitric oxide (NO) and superoxide (O(2)(*-)) production by the intestinal vascular endothelium may contribute to NEC-related intestinal injury.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) and superoxide (O(2)(*-)) production in the progression of intestinal injury in a rat model of necrotizing enterocolitis (NEC).
• To determine the involvement of nitric oxide synthase (NOS) in the observed changes in NO and O(2)(*-) production during NEC development.

Main Methods:

• Neonatal rat pups were subjected to formula feeding and hypoxia (FF/H) or formula feeding, hypoxia, and lipopolysaccharide (FF/H/LPS) to model NEC.
• Mesenteric tissues were analyzed for NO and O(2)(*-) production, with and without NOS inhibition using N(G)-monomethyl-L-arginine (L-NMMA).
• Western blot analysis assessed levels of endothelial NOS (eNOS), phosphorylated eNOS (phospho-eNOS), and inducible NOS (iNOS); intestinal injury was graded histologically.

Main Results:

• The FF/H/LPS group exhibited severe intestinal injury (grade 3-4), while the FF/H group showed mild injury (grade 1-2).
• NEC progression was associated with a shift from increased NO and decreased O(2)(*-) in FF/H pups to decreased NO and increased O(2)(*-) in FF/H/LPS pups.
• NOS inhibition affected O(2)(*-) production in all groups and NO production in control and FF/H groups; phospho-eNOS increased in FF/H, and iNOS increased in FF/H/LPS.

Conclusions:

• Intestinal ischemia in NEC progression is linked to a NOS-dependent shift from NO to O(2)(*-) production.
• This shift may result in impaired vasodilation and excessive reactive oxygen species (ROS) generation, exacerbating intestinal injury.
• Understanding these vascular mechanisms is crucial for developing targeted therapies for NEC.